AAAAAA
Results: 76-100/126
Authors:
PAOLOROSSI F
VILLA S
BARNI S
TANCINI G
ANDRES M
LISSONI P
Citation: F. Paolorossi et al., 2ND-LINE THERAPY WITH INTERFERON-ALPHA PLUS VINBLASTINE IN METASTATICRENAL-CELL CANCER-PATIENTS PROGRESSED UNDER INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY, Tumori, 81(1), 1995, pp. 45-47
Authors:
NANO R
BARNI S
CAPELLI E
PROSPERI E
LAVEZZI L
SALVUCCI O
Citation: R. Nano et al., DNA-PROTEIN CELL CONTENT OF LYMPHOKINE-ACTIVATED KILLER (LAK) AND TARGET-CELLS IN COCULTURE, Anticancer research, 15(3), 1995, pp. 751-754
Authors:
LABIANCA R
MARSONI S
PANCERA G
TORRI V
ZANIBONI A
ERLICHMAN C
PATER J
SHEPHERD L
ZEE B
SEITZ JF
MILAN C
PIGNON JP
AITINI E
APOLONE G
AUZZANI A
BANDUCCI S
BARNI S
BERETTA GD
BIFFI O
BUCCI F
CARDI G
CIFATTE D
COLUCCI G
COMANDONE A
COMELLA G
CONFALONIERI C
CONFU A
COSTANZO M
CRESPI C
DAMIANI E
DEGIORGI D
DONGIOVANNI V
FABRIS G
FABRIZIO G
FACENDOLA G
FANTONI PA
FERRAGNI A
FIORI B
FLORIANELLO F
FRONTINI L
GALLI E
GARATTINI P
GHERARDI G
GIOVANELLI A
GUILIANI F
GOSSO P
JANNIELLO GP
KILDANI B
LEO S
LIBERATI A
MAFFIONE G
MAIELLO E
MAIORINO L
MANENTE P
MARTIGNONI GC
MARZOLA M
MASTRODONATO M
MERIGGI F
MOLINARI B
MOLINARI GF
MONFERRONI N
NASCIMBEN O
NATALE C
NEGRETTI S
PALAZZO S
PANVINI D
PARISI V
PEDICINI T
PERADOTTO F
PESSA S
PIATTO E
PIZZI G
PROSPERI A
PRUSCIANO F
RABBI C
RAINA A
RUGGIERO A
SAVA C
SCANZI F
CARRARO PS
SMERIERI F
STIVALA B
TAIANA A
TARDIO B
TESTORE F
TINAZZI A
TURCATO G
ZONATO S
AYOUB J
BELANGER K
BIRON G
BODURTHA AJ
BOOS G
BURNELL M
CANO P
CHARPENTIER D
CHOW WSW
CHRITCHLEY J
CRIPPS C
DANG SP
DAVIS ML
DAVIDSON M
DINGLE B
DRYER D
FERLAND E
FIELDS A
FINE S
JOLIVET J
KAISER L
KERR I
KOCHA WI
KOTWALL C
KRIEGER H
LEPINEMARTIN M
LITTLE C
LOFTERS WS
MAHEU M
MOORE M
PRESSNAIL B
RAGAZ J
RAUNER H
REZNICK R
ROSS T
ROTSTEIN L
RUDINSKAS L
SCHACTER B
SHAH A
SKILLINGS J
STERN H
TWEEDDALE M
VANDENBERG T
WALDE D
WATT HJ
WONG KWA
YOSHIDA S
BALDIT C
BARONI JL
BAZIN JP
BEDENNE L
BLANCHI A
BOGNEL JC
BOSSET JF
BOUCHE O
BRANDONE JM
BRICOT R
BURTIN P
CADOR L
CHARBIT M
CHARLIER A
COUROUBLE Y
COUZIGOU P
CUILLERET J
DELPERO JR
DUCREUX M
DUMAS F
ECHINARD E
ETIENNE PL
FRIGUET JL
GIGNOUX M
GIOVANNINI M
HERR JP
LAFON J
LETREUT P
LATRIVE JP
LAUVAUX C
LOUVET C
MACKIEWICZ R
MAUREL C
MESSERSCHMITT C
MORAND L
MOREAU J
MORIN T
NORDLINGER B
NOTERDAEME PM
OLLIER JC
PICAUD R
PEINKOWSKI P
PLACHOT JP
PORTET R
DUBATY HR
ROUGIER P
ROZENTAL G
SASTRE B
VOTTELAMBERT A
WATRIN B
ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
Authors:
LISSONI P
BARNI S
CAZZANIGA M
ARDIZZOIA A
ROVELLI F
TANCINI G
BRIVIO F
FRIGERIO F
Citation: P. Lissoni et al., PREDICTION OF RECURRENCE IN OPERABLE BREAST-CANCER BY POSTOPERATIVE CHANGES IN PROLACTIN SECRETION, Oncology, 52(6), 1995, pp. 439-442
Authors:
LISSONI P
BARNI S
BRIVIO F
ROSSINI F
FUMAGALLI L
ARDIZZOIA A
TANCINI G
Citation: P. Lissoni et al., A BIOLOGICAL STUDY ON THE EFFICACY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN THE TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA, Oncology, 52(5), 1995, pp. 360-362
Authors:
BARNI S
LISSONI P
CAZZANIGA M
ARDIZZOIA A
MEREGALLI S
FOSSATI V
FUMAGALLI L
BRIVIO F
TANCINI G
Citation: S. Barni et al., A RANDOMIZED STUDY OF LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VERSUS SUPPORTIVE CARE ALONE IN METASTATIC COLORECTAL-CANCER PATIENTS PROGRESSING UNDER 5-FLUOROURACIL AND FOLATES, Oncology, 52(3), 1995, pp. 243-245
Authors:
LISSONI P
BARNI S
TANCINI G
MAININI E
PIGLIA F
MAESTRONI GJM
LEWINSKI A
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUSMELATONIN OF LOCALLY ADVANCED OR METASTATIC ENDOCRINE TUMORS, Oncology, 52(2), 1995, pp. 163-166
Authors:
ZANIBONI A
BARNI S
LABIANCA R
MARINI G
PANCERA G
GIACCON G
PIAZZA E
SIGNAROLDI A
LEGNANI W
LUPORINI G
Citation: A. Zaniboni et al., EPIRUBACIN, CISPLATIN, AND CONTINUOUS-INFUSION 5-FLUOROURACIL IS AN ACTIVE AND SAFE REGIMEN FOR PATIENTS WITH ADVANCED GASTRIC-CANCER - AN ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD) REPORT, Cancer, 76(10), 1995, pp. 1694-1699
Authors:
LISSONI P
BARNI S
MEREGALLI S
FOSSATI V
CAZZANIGA M
ESPOSTI D
TANCINI G
Citation: P. Lissoni et al., MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE, British Journal of Cancer, 71(4), 1995, pp. 854-856
Authors:
LISSONI P
ARDIZZOIA A
MEREGALLI S
BARNI S
FOSSATI V
BRIVIO F
TANCINI G
Citation: P. Lissoni et al., A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA, Oncology Reports, 1(6), 1994, pp. 1277-1280
Authors:
ALDEGHI R
LISSONI P
BARNI S
ARDIZZOIA A
TANCINI G
PIPERNO A
POZZI M
RICCI G
CONTI A
MAESTRONI GJM
Citation: R. Aldeghi et al., LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY IN ASSOCIATION WITHTHE PINEAL HORMONE MELATONIN AS A FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR-CARCINOMA, European journal of cancer, 30A(2), 1994, pp. 167-170
Authors:
LABIANCA R
GIACCON G
BARNI S
AMBROSINI G
IIRILLO A
FIORENTINI G
DURO M
PIAZZA E
OLIANI C
PANCERA G
CASCINU S
MARTIGNONI G
ZANIBONI A
DALLAVALLE G
LUPORINI G
Citation: R. Labianca et al., DOUBLE-MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER WITH LOW-DOSE INTERFERON-ALPHA-2B AND FOLINIC ACID - THE GISCAD EXPERIENCE, European journal of cancer, 30A(11), 1994, pp. 1611-1616
Authors:
GASPARINI G
CAFFO O
BARNI S
FRONTINI L
TESTOLIN A
GUGLIELMI RB
AMBROSINI G
Citation: G. Gasparini et al., VINORELBINE IS AN ACTIVE ANTIPROLIFERATIVE AGENT IN PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2094-2101
Authors:
LISSONI P
BARNI S
TANCINI G
BRIVIO F
TISI E
ZUBELEWICZ B
BRACZKOWSKI R
Citation: P. Lissoni et al., ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 126-129
Authors:
BRACKOWSKI R
ZUBELEWICZ B
ROMANOWSKI W
LISSONI P
BARNI S
TANCINI G
MAESTRONI GJM
Citation: R. Brackowski et al., PRELIMINARY-STUDY ON MODULATION OF THE BIOLOGICAL EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ADVANCED CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(3), 1994, pp. 77-80
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
FOSSATI V
PAOLOROSSI F
TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
FOSSATI V
PAOLOROSSI F
TANCINI G
Citation: P. Lissoni et al., WEEKLY EPIRUBICIN PLUS LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY INBREAST-CANCER - PRELIMINARY IMMUNOBIOLOGICAL RESULTS, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 53-55
Authors:
LISSONI P
BASTONE A
BARNI S
TANCINI G
GALLI MA
Citation: P. Lissoni et al., NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 65-66
Authors:
LISSONI P
BASTONE A
BARNI S
TANCINI G
GALLI MA
Citation: P. Lissoni et al., NORMALIZATION OF IDIOPATHIC ARTERIAL-HYPERTENSION FOLLOWING CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 8(2), 1994, pp. 65-66
Authors:
LISSONI P
BRIVIO F
FUMAGALLI L
GALIMBERTI C
CATALDO M
MARSILI MT
BRIVIO O
BARNI S
TANCINI G
ANGELINI A
Citation: P. Lissoni et al., A STUDY OF INTERACTIONS AMONG MARKERS OF MACROPHAGE FUNCTIONS IN METASTATIC SOLID TUMORS - NEOPTERIN LEVELS IN RELATION TO THOSE OF TUMOR-NECROSIS-FACTOR-ALPHA AND OF SOLUBLE INTERLEUKIN-2 RECEPTORS, Journal of biological regulators and homeostatic agents, 8(1), 1994, pp. 32-35
Authors:
BARNI S
BERNINI F
FENOGLIO C
REGGIANI C
Citation: S. Barni et al., ADAPTATIONS OF THE FROG MYOCARDIUM TO CONDITIONS OF NATURAL HIBERNATION - MORPHOFUNCTIONAL CHANGES, Bollettino di zoologia, 61(4), 1994, pp. 317-324
Authors:
LISSONI P
MEREGALLI S
FOSSATI V
PAOLOROSSI F
BARNI S
TANCINI G
FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN VS CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE CISPLATIN AND ETOPOSIDE AS FIRST-LINE, Tumori, 80(6), 1994, pp. 464-467
Authors:
BARNI S
ARDIZZOIA A
BERNARDO G
VILLA S
STRADA MR
CAZZANIGA M
ARCHILI C
FRONTINI L
Citation: S. Barni et al., VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER, Tumori, 80(4), 1994, pp. 280-282
Authors:
BARNI S
ARDIZZOIA A
BERNARDO G
VILLA S
STRADA MR
CAZZANIGA M
ARCHILI C
FRONTINI L
Citation: S. Barni et al., VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER, Tumori, 80(4), 1994, pp. 280-282
Authors:
LISSONI P
BARNI S
ANDRES M
SCARDINO E
VIGORE L
VEZZO R
RESCALDANI R
TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285